U.S. Senator Bernie Sanders plans to send a letter to Catalyst Pharmaceuticals on Monday asking it to justify its decision to charge US$375,000 annually for a medication that for years has been available to patients for free.
- Florida Dems Accuse Bernie Sanders of Refusing to Condemn Maduro as Dictator
- Khloe Kardashian and Kylie Jenner will not answer Jordyn Woods calls
- 10 funds with the biggest positions in Kraft Heinz
- HSBC: Looking vulnerable
- Resetting Astro
- Don’t Say Bojio: Up To 70% Off at Toys ‘R’ Us Warehouse Sale At Outram (Till 3 March)
- Not only HDB but leasehold private property time bomb has also started ticking